-
Mashup Score: 0
New research suggests that some cancer patients do not have their menstrual history documented and do not receive treatment for menstrual disturbances.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 8The 2022 OncoAlert Colloquium DAY 1: Breast Cancer - 1 year(s) ago
A warm welcome to the third OncoAlert ColloquiumThis year being held in partnership with: The American Society for Radiation OncologyThe European Cancer Orga…
Source: YouTubeCategories: Latest Headlines, Oncologists2Tweet-
RT @OncoAlert: The #OncoAlertColloquium 🚨 🌟NOW OVER9⃣,0⃣0⃣0⃣VIEWERS🌟 Day 1⃣#BreastCancer https://t.co/FHgVESaqa2 Day2⃣GU Oncology https:/…
-
The #OncoAlertColloquium 🚨 🌟NOW OVER9⃣,0⃣0⃣0⃣VIEWERS🌟 Day 1⃣#BreastCancer https://t.co/FHgVESaqa2 Day2⃣GU Oncology https://t.co/93OqZ3nfUc Day3⃣ #LungCancer https://t.co/SSoCFZrzpW Day4⃣ #GynOnc https://t.co/vxiwdxlcna Day5⃣GI Oncology https://t.co/JUGy3nq5YC Day6⃣EONS… https://t.co/SewOM5aZgl https://t.co/vT0vxMEgS6
-
-
Mashup Score: 0
New research suggests that, for patients with ovarian cancer, the risk of VTE increases as patients receive more lines of chemotherapy.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Division Chief of Gynecologic Oncology - Miami, Florida (US) job with University of Miami Health System | 7616900 - 1 year(s) ago
Sylvester Comprehensive Cancer Center’s Division of Gynecologic Oncology at the University of Miami Health System and Miller School of Medicine, ha…
Source: ASCO Career CenterCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 6The 2022 OncoAlert Colloquium DAY 1: Breast Cancer - 1 year(s) ago
A warm welcome to the third OncoAlert ColloquiumThis year being held in partnership with: The American Society for Radiation OncologyThe European Cancer Orga…
Source: YouTubeCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @OncoAlert: The #OncoAlertColloquium 🚨 🌟NOW OVER8⃣,5⃣0⃣0⃣VIEWERS🌐🌟 Day1⃣ #BreastCancer https://t.co/FHgVESaqa2 Day2⃣GU https://t.co/93…
-
-
Mashup Score: 0Chatbot more cost-effective for finding high-risk pathogenic variants in cancer genes - 1 year(s) ago
A cloud-based chatbot considerably improved identification of high-risk pathogenic variants in cancer genes, according to study results.The chatbot identified three times as many patients with high-risk pathogenic variants and did so at a much lower cost, findings presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer showed.
Source: www.healio.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Abortion Restrictions May Affect More than 20% of Pregnant Cancer Patients in the US - 1 year(s) ago
More than 20% of US patients diagnosed with cancer during pregnancy may be unable to terminate that pregnancy due to abortion laws in their state, a new study suggests.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
Patients with advanced or recurrent endometrial cancer spend about 15% of their time addressing health care needs, and this time burden can have a negative effect on their quality of life, a study suggests.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2
Patients with advanced ovarian cancer may live longer if they undergo minimally invasive surgery rather than laparotomy, a study suggests.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
One of every four patients with a gynecologic oncology office visit had inadequate levels of cancer health literacy, according to data presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.Researchers found racial and ethnic minorities, as well as patients with a lower income or a language barrier, more likely to have poor cancer health literacy.
Source: www.healio.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
New research suggests that some cancer patients do not have their menstrual history documented and do not receive treatment for menstrual disturbances. Published in @JNCCN. https://t.co/KFUkPlywRk #CancerCare #GynOnc